HealthHoly Grail 'Smart Insulin' Offers New Hope for Type 1 Diabetes Patients Joint researchers from three countries developed a glucose-responsive "smart insulin" that can be a game-changer for millions of patients with type 1 diabetes.by Joseph Henry
HealthHims & Hers Selling Affordable Weight Loss Drugs Not Approved by FDA: Here's the Risksby Quincy Jon
HealthCellphone Compass Enables Precision Measurements, Revolutionizing Glucose Monitoringby Inno Flores
HealthYogurt Gets Nod from FDA: Limited Evidence Suggests Reduction in Type 2 Diabetes Riskby Quincy Jon
HealthBiotech Startup Wants Insulin More Affordable: How Can 'Biosimilar' Make a Difference?by Joseph Henry
HealthDoes Ozempic and Wegovy Increase the Risk of Suicidal Thoughts? New Study Reveals the Answerby Jace Dela Cruz
HealthDiabetes Relief: Major Manufacturers Cap Insulin Prices at $35, Answering Calls for Affordability in the USby Quincy Jon
HealthPharmaceutical Giant Servier Ordered to Pay $460 Million Over Deaths Linked to Diabetes Drugby Quincy Jon
Snapdragon 8 Elite Is Qualcomm's Answer to Apple's A18 Pro, Apple Intelligence, But Can It Rise Above?